scholarly journals Duke University Medical Center Perioperative Diabetes Management Program

2021 ◽  
pp. cd200029
Author(s):  
Tara A. Lenk ◽  
John Whittle ◽  
Solomon Aronson ◽  
Timothy E. Miller ◽  
Matthew Fuller ◽  
...  
2021 ◽  
Author(s):  
Tara A. Lenk ◽  
John Whittle ◽  
Solomon Aronson ◽  
Timothy E. Miller ◽  
Matthew Fuller ◽  
...  

The following article describes a project at an academic tertiary-care medical center aimed at identifying surgical patients with uncontrolled diabetes early in the preoperative process to improve their perioperative glycemic control and surgical outcomes.


2021 ◽  
Author(s):  
Tara A. Lenk ◽  
John Whittle ◽  
Solomon Aronson ◽  
Timothy E. Miller ◽  
Matthew Fuller ◽  
...  

The following article describes a project at an academic tertiary-care medical center aimed at identifying surgical patients with uncontrolled diabetes early in the preoperative process to improve their perioperative glycemic control and surgical outcomes.


1990 ◽  
Vol 16 (5) ◽  
pp. 389-393 ◽  
Author(s):  
Debra J. Drozda ◽  
Veronica A. Dawson ◽  
Dorothy J. Long ◽  
Lisa S. Freson ◽  
Marka. Sperling

Admission records at Children's Hospital Medical Center in Cincinnati were reviewed to determine the impact of a compre hensive diabetes management program on selected indicators of health status in children with diabetes mellitus. Two periods were compared: January 1973 through June 1978 (periodA), prior to institution of the program, and July 1978 through December 1987 (period B). Although the number of children admitted with a diagnosis of type I diabetes not associated with DKA or other diagnoses increased by 10 % during these 10 years, the number of children with diabetic ketoacidosis (DKA) not associated with other diagnoses fell from 58% in period A to 24% in period B. Similarly, average length of stay for the reported DKA admissions decreased from a mean of 5.84 days in period A to a mean of 4. 62 days in period B. This reduction of 1.2 days saved an estimated $342,000 in hospi talization costs. These findings suggest that a comprehensive diabetes management program consisting of medical treatment, education, and psychological support services, has a positive influence on patient outcome and can be cost effective.


2011 ◽  
Vol 37 (5) ◽  
pp. 680-688 ◽  
Author(s):  
Garry Welch ◽  
Nancy A. Allen ◽  
Sofija E. Zagarins ◽  
Kelly D. Stamp ◽  
Sven-Erik Bursell ◽  
...  

2005 ◽  
Vol 39 (11) ◽  
pp. 1828-1832 ◽  
Author(s):  
Patrick J Kiel ◽  
Amie D McCord

BACKGROUND Clinical outcomes resulting from pharmaceutical care have been incompletely addressed in the diabetes population. We conducted a retrospective study evaluating clinical outcomes in a diabetes disease management program in which clinical pharmacists possessed collaborative practice agreements. OBJECTIVE To evaluate changes in clinical outcomes for patients enrolled in a pharmacist-coordinated diabetes management program. METHODS Medical records of 157 patients enrolled in the diabetes management program between June 2003 and April 2004 were retrospectively reviewed. Data collection included baseline and follow-up values for hemoglobin A1C (A1C) and lipids as well as frequency of adherence to preventive care, including annual foot and eye examinations and daily aspirin therapy. RESULTS For patients with both baseline and follow-up data, the mean A1C reduction was 1.6% (n = 109; p < 0.001). For patients with an initial A1C of ≥8.5%, the mean reduction was 2.7% (n = 57; p < 0.001). The percentage of patients with A1C ≤7% increased from 19% at baseline to 50% at follow-up (p < 0.001). The mean low-density lipoprotein (LDL) reduction observed was 16 mg/dL (n = 73; NS) and the percentage of patients with LDL values ≤100 mg/dL increased from 30% at baseline to 56% at follow-up (p < 0.001). The frequency of microalbumin screening increased by 27% (p < 0.001), and the number of patients with annual eye and foot examinations increased by 27% (p < 0.05) and 15% (p < 0.05), respectively. The percentage of patients who had a positive microalbumin test and were taking a renal protective agent rose 19% from baseline to follow-up (NS). The percentage of patients taking daily aspirin increased from 42% at baseline to 80% at follow-up (p < 0.01). CONCLUSIONS The pharmacist-coordinated diabetes management program was effective in improving clinical markers for enrolled patients. Significant improvements were observed in A1C and LDL values as well as the frequency of adherence to preventive care.


Sign in / Sign up

Export Citation Format

Share Document